Ventricular Septal Defect: Clinical Trials

3 trials for Ventricular Septal Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1
Phase 11Completed 1

Follow Ventricular Septal Defect: new trials by email Literature Review of Ventricular Septal Defect trials Research Report on Ventricular Septal Defect

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optical Tissue Identification for Myocardial Architecture
Fluorescite, Cellvizio 100 Series System with Confocal Miniprobes - Ventricular Septal Defect, Complete Atrioventricular Canal
Phase 2Active not recruitingAditya Kaza702019-12-202023-06-15
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Intravenous L-Citrulline, Placebo of Intravenous L-Citrulline - Atrial Septal Defect, Ventricular Septal Defect
Phase 1 / Phase 2CompletedAsklepion Pharmaceuticals, LLC222010-09-012022-07-27
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
saline, ketamine - Ventricular Septal Defect
Phase 2CompletedArkansas Children's Hospital Research Institute242004-07-012007-11-12

Narrower conditions

Heart Septal Defects, Ventricular (3)  ·  Atrioventricular Septal Defect (1)  ·  Complete atrioventricular septal defect (1)  ·  Heart Septal Defects, Atrial (1)

Broader conditions

Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Heart Defects, Congenital (3)  ·  Heart Diseases (3)  ·  Heart Septal Defects (3)

Interventions

Fluorescein (1)  ·  Ketamine (1)  ·  Sodium Chloride (1)

Sponsors

Aditya Kaza (1)  ·  Arkansas Children's Hospital Research Institute (1)  ·  Asklepion Pharmaceuticals, LLC (1)

Countries

United States (3)

Top investigators

Aditya K Kaza, MD (1)  ·  Adnan T Bhutta, MD (1)  ·  Allan Doctor, MD (1)  ·  Catherine Krawczeski, MD (1)  ·  Frederick E Barr, MD (1)

Results publications

PMID 21926656

NIH funding

R56HL128813 (1)